A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial

Peter Richmond, M.D. Nissen, H.S. Marshall, S.B. Lambert, D. Roberton, W.C. Gruber, T.R. Jones, A. Arora

    Research output: Contribution to journalArticle

    43 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)6163-6174
    JournalVaccine
    Volume30
    Issue number43
    DOIs
    Publication statusPublished - 2012

    Cite this